Advanced Topics
Overview
DRAGEN Heme WGS Tumor Only Pipeline, henceforth referred as the Heme Pipeline, is a comprehensive and unbiased whole genome sequencing solution to replace conventional cytogenetic and panel sequencing approaches for detecting all types of mutation using a limited amount of DNA. It can be applied to detect clinically actionable mutations for cancer spanning a wide range of genomic events, e.g., structural variants (SV), Copy Number Alterations (CNA), small variants (SNV/insertion/deletion/delins) and internal tandem duplications (ITD) and DUX4 variants using Heme samples.
The Heme pipeline includes a DNA-only workflow designed to analyze whole genome sequencing data generated on supported instruments. It may be run as a local off-instrument solution installable on a DRAGEN server or accessible through the Illumina Connected Analytics (ICA) cloud environment. The Heme pipeline is for Research Use Only (RUO).
Features
Superb performance based on the DRAGEN BioIT platform Release 4.4.4
Supports starting the analysis from BCL, FASTQ, BAM or CRAM as inputs.
Flexible custom configurable options on top of well established DRAGEN recipes for Heme WGS analysis.
Available on local DRAGEN servers and Illumina Connected Analytics (ICA)
Seamless integration with Illumina Connected Insights (ICI) for tertiary interpretation
Supported Library Prep Kits (LPKs)
Illumina DNA PCR Free Prep Kit
Illumina DNA Prep Kit
Custom LPKs
Supported Sequencing Instruments
NovaSeq 6000 or 6000Dx in RUO mode
NovaSeq X or NovaSeq X plus
Last updated
Was this helpful?